Basis of Presentation - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Inventory [Line Items]
Accumulated deficit	$ 203,260		$ 203,260		$ 143,422
Cash flows from operations			(71,555)	$ (34,703)	(40,556)
Cash on hand	23,174	$ 114,896	23,174	114,896	95,054	$ 17,009
Restructuring charges	1,204
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Increase in cost of revenues	12,746	16,624	37,254	37,272
Increase in operating expenses	26,434	$ 28,642	83,872	$ 63,544
Revision of Prior Period, Error Correction, Adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Out-of-period adjustment to net income	1,290
Increase in cost of revenues	665
Increase in operating expenses	675
Customers For Which Returns Are Expected To Be Received
Inventory [Line Items]
Accrued sales returns resulting from FDA Warning Letter	$ 6,843		$ 6,843		$ 20,145